Global Cancer Respiratory Biopsy Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cancer Respiratory Biopsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
  • 1.2.2 Mass Spectrometry Technology Based Respiratory Detection
  • 1.2.3 Gas Chromatography-Mass Spectrometry Based Respiratory Detection
  • 1.2.4 Sensor Based Respiratory Detection
• 1.3 Market by Application
  • 1.3.1 Global Cancer Respiratory Biopsy Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Lung Cancer Early Screening
  • 1.3.3 Colorectal Cancer Detection
  • 1.3.4 Liver Cancer Detection
  • 1.3.5 Esophageal Cancer Detection
  • 1.3.6 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Respiratory Biopsy Market Perspective (2020-2031)
• 2.2 Global Cancer Respiratory Biopsy Growth Trends by Region
  • 2.2.1 Global Cancer Respiratory Biopsy Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Cancer Respiratory Biopsy Market Size by Region (2020-2031)
• 2.3 Cancer Respiratory Biopsy Market Dynamics
  • 2.3.1 Cancer Respiratory Biopsy Industry Trends
  • 2.3.2 Cancer Respiratory Biopsy Market Drivers
  • 2.3.3 Cancer Respiratory Biopsy Market Challenges
  • 2.3.4 Cancer Respiratory Biopsy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Cancer Respiratory Biopsy by Players
  • 3.1.1 Global Cancer Respiratory Biopsy Revenue by Players (2020-2025)
  • 3.1.2 Global Cancer Respiratory Biopsy Revenue Market Share by Players (2020-2025)
• 3.2 Global Cancer Respiratory Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Cancer Respiratory Biopsy, Ranking by Revenue, 2023 VS 2024 VS 2025
• 3.4 Global Market Concentration Ratio
  • 3.4.1 Global Cancer Respiratory Biopsy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Respiratory Biopsy Revenue in 2024
• 3.5 Global Key Players of Cancer Respiratory Biopsy Head office and Area Served
• 3.6 Global Key Players of Cancer Respiratory Biopsy, Product and Application
• 3.7 Global Key Players of Cancer Respiratory Biopsy, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global Cancer Respiratory Biopsy Historic Market Size by Type (2020-2025)
• 4.2 Global Cancer Respiratory Biopsy Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

• 5.1 Global Cancer Respiratory Biopsy Historic Market Size by Application (2020-2025)
• 5.2 Global Cancer Respiratory Biopsy Forecasted Market Size by Application (2026-2031)

6 North America

• 6.1 North America Cancer Respiratory Biopsy Market Size (2020-2031)
• 6.2 North America Market Size by Type
  • 6.2.1 North America Cancer Respiratory Biopsy Market Size by Type (2020-2031)
  • 6.2.2 North America Cancer Respiratory Biopsy Market Share by Type (2020-2031)
• 6.3 North America Market Size by Application
  • 6.3.1 North America Cancer Respiratory Biopsy Market Size by Application (2020-2031)
  • 6.3.2 North America Cancer Respiratory Biopsy Market Share by Application (2020-2031)
• 6.4 North America Market Size by Country
  • 6.4.1 North America Cancer Respiratory Biopsy Market Size by Country: 2020 VS 2024 VS 2031
  • 6.4.2 North America Cancer Respiratory Biopsy Market Size by Country (2020-2031)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Cancer Respiratory Biopsy Market Size (2020-2031)
• 7.2 Europe Market Size by Type
  • 7.2.1 Europe Cancer Respiratory Biopsy Market Size by Type (2020-2031)
  • 7.2.2 Europe Cancer Respiratory Biopsy Market Share by Type (2020-2031)
• 7.3 Europe Market Size by Application
  • 7.3.1 Europe Cancer Respiratory Biopsy Market Size by Application (2020-2031)
  • 7.3.2 Europe Cancer Respiratory Biopsy Market Share by Application (2020-2031)
• 7.4 Europe Market Size by Country
  • 7.4.1 Europe Cancer Respiratory Biopsy Market Size by Country: 2020 VS 2024 VS 2031
  • 7.4.2 Europe Cancer Respiratory Biopsy Market Size by Country (2020-2025)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China Cancer Respiratory Biopsy Market Size (2020-2031)
• 8.2 China Market Size by Type
  • 8.2.1 China Cancer Respiratory Biopsy Market Size by Type (2020-2031)
  • 8.2.2 China Cancer Respiratory Biopsy Market Share by Type (2020-2031)
• 8.3 China Market Size by Application
  • 8.3.1 China Cancer Respiratory Biopsy Market Size by Application (2020-2031)
  • 8.3.2 China Cancer Respiratory Biopsy Market Share by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Cancer Respiratory Biopsy Market Size (2020-2031)
• 9.2 Asia Market Size by Type
  • 9.2.1 Asia Cancer Respiratory Biopsy Market Size by Type (2020-2031)
  • 9.2.2 Asia Cancer Respiratory Biopsy Market Share by Type (2020-2031)
• 9.3 Asia Market Size by Application
  • 9.3.1 Asia Cancer Respiratory Biopsy Market Size by Application (2020-2031)
  • 9.3.2 Asia Cancer Respiratory Biopsy Market Share by Application (2020-2031)
• 9.4 Asia Market Size by Region
  • 9.4.1 Asia Cancer Respiratory Biopsy Market Size by Region: 2020 VS 2024 VS 2031
  • 9.4.2 Asia Cancer Respiratory Biopsy Market Size by Region (2020-2031)
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 China Taiwan
  • 9.4.6 Southeast Asia
  • 9.4.7 India
  • 9.4.8 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Cancer Respiratory Biopsy Market Size (2020-2031)
• 10.2 Middle East, Africa, and Latin America Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Cancer Respiratory Biopsy Market Size by Type (2020-2031)
  • 10.2.2 Middle East, Africa, and Latin America Cancer Respiratory Biopsy Market Share by Type (2020-2031)
• 10.3 Middle East, Africa, and Latin America Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Cancer Respiratory Biopsy Market Size by Application (2020-2031)
  • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
• 10.4 Middle East, Africa, and Latin America Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Cancer Respiratory Biopsy Market Size by Country: 2020 VS 2024 VS 2031
  • 10.4.2 Middle East, Africa, and Latin America Cancer Respiratory Biopsy Market Size by Country (2020-2031)
  • 10.4.3 Brazil
  • 10.4.4 Mexico
  • 10.4.5 Turkey
  • 10.4.6 Saudi Arabia
  • 10.4.7 Israel
  • 10.4.8 GCC Countries

11 Key Players Profiles

• 11.1 Owlstone Medical
  • 11.1.1 Owlstone Medical Company Details
  • 11.1.2 Owlstone Medical Business Overview
  • 11.1.3 Owlstone Medical Cancer Respiratory Biopsy Introduction
  • 11.1.4 Owlstone Medical Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.1.5 Owlstone Medical Recent Development
• 11.2 Breath Diagnostics
  • 11.2.1 Breath Diagnostics Company Details
  • 11.2.2 Breath Diagnostics Business Overview
  • 11.2.3 Breath Diagnostics Cancer Respiratory Biopsy Introduction
  • 11.2.4 Breath Diagnostics Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.2.5 Breath Diagnostics Recent Development
• 11.3 Menssana Research
  • 11.3.1 Menssana Research Company Details
  • 11.3.2 Menssana Research Business Overview
  • 11.3.3 Menssana Research Cancer Respiratory Biopsy Introduction
  • 11.3.4 Menssana Research Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.3.5 Menssana Research Recent Development
• 11.4 Sensigent
  • 11.4.1 Sensigent Company Details
  • 11.4.2 Sensigent Business Overview
  • 11.4.3 Sensigent Cancer Respiratory Biopsy Introduction
  • 11.4.4 Sensigent Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.4.5 Sensigent Recent Development
• 11.5 Alpha Szenszor
  • 11.5.1 Alpha Szenszor Company Details
  • 11.5.2 Alpha Szenszor Business Overview
  • 11.5.3 Alpha Szenszor Cancer Respiratory Biopsy Introduction
  • 11.5.4 Alpha Szenszor Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.5.5 Alpha Szenszor Recent Development
• 11.6 NanoScent
  • 11.6.1 NanoScent Company Details
  • 11.6.2 NanoScent Business Overview
  • 11.6.3 NanoScent Cancer Respiratory Biopsy Introduction
  • 11.6.4 NanoScent Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.6.5 NanoScent Recent Development
• 11.7 Spira Innovation
  • 11.7.1 Spira Innovation Company Details
  • 11.7.2 Spira Innovation Business Overview
  • 11.7.3 Spira Innovation Cancer Respiratory Biopsy Introduction
  • 11.7.4 Spira Innovation Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.7.5 Spira Innovation Recent Development
• 11.8 Syft Technologies
  • 11.8.1 Syft Technologies Company Details
  • 11.8.2 Syft Technologies Business Overview
  • 11.8.3 Syft Technologies Cancer Respiratory Biopsy Introduction
  • 11.8.4 Syft Technologies Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.8.5 Syft Technologies Recent Development
• 11.9 Breathe Biomedical
  • 11.9.1 Breathe Biomedical Company Details
  • 11.9.2 Breathe Biomedical Business Overview
  • 11.9.3 Breathe Biomedical Cancer Respiratory Biopsy Introduction
  • 11.9.4 Breathe Biomedical Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.9.5 Breathe Biomedical Recent Development
• 11.10 Vocxi Health
  • 11.10.1 Vocxi Health Company Details
  • 11.10.2 Vocxi Health Business Overview
  • 11.10.3 Vocxi Health Cancer Respiratory Biopsy Introduction
  • 11.10.4 Vocxi Health Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.10.5 Vocxi Health Recent Development
• 11.11 BREAX Biotech
  • 11.11.1 BREAX Biotech Company Details
  • 11.11.2 BREAX Biotech Business Overview
  • 11.11.3 BREAX Biotech Cancer Respiratory Biopsy Introduction
  • 11.11.4 BREAX Biotech Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.11.5 BREAX Biotech Recent Development
• 11.12 ChromX Health
  • 11.12.1 ChromX Health Company Details
  • 11.12.2 ChromX Health Business Overview
  • 11.12.3 ChromX Health Cancer Respiratory Biopsy Introduction
  • 11.12.4 ChromX Health Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.12.5 ChromX Health Recent Development
• 11.13 Sunvou Medical
  • 11.13.1 Sunvou Medical Company Details
  • 11.13.2 Sunvou Medical Business Overview
  • 11.13.3 Sunvou Medical Cancer Respiratory Biopsy Introduction
  • 11.13.4 Sunvou Medical Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.13.5 Sunvou Medical Recent Development
• 11.14 MaiAoTech
  • 11.14.1 MaiAoTech Company Details
  • 11.14.2 MaiAoTech Business Overview
  • 11.14.3 MaiAoTech Cancer Respiratory Biopsy Introduction
  • 11.14.4 MaiAoTech Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.14.5 MaiAoTech Recent Development
• 11.15 Hanon Instruments
  • 11.15.1 Hanon Instruments Company Details
  • 11.15.2 Hanon Instruments Business Overview
  • 11.15.3 Hanon Instruments Cancer Respiratory Biopsy Introduction
  • 11.15.4 Hanon Instruments Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.15.5 Hanon Instruments Recent Development
• 11.16 WIM Spirare
  • 11.16.1 WIM Spirare Company Details
  • 11.16.2 WIM Spirare Business Overview
  • 11.16.3 WIM Spirare Cancer Respiratory Biopsy Introduction
  • 11.16.4 WIM Spirare Revenue in Cancer Respiratory Biopsy Business (2020-2025)
  • 11.16.5 WIM Spirare Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Cancer Respiratory Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Mass Spectrometry Technology Based Respiratory Detection

Table 3. Key Players of Gas Chromatography-Mass Spectrometry Based Respiratory Detection

Table 4. Key Players of Sensor Based Respiratory Detection

Table 5. Global Cancer Respiratory Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Cancer Respiratory Biopsy Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Market Size by Region (2020-2031) & (US$ Million)

Table 8. Global Cancer Respiratory Biopsy Market Share by Region (2020-2031)

Table 9. Market Trends

Table 10. Market Drivers

Table 11. Market Challenges

Table 12. Market Restraints

Table 13. Global Cancer Respiratory Biopsy Revenue by Players (2020-2025) & (US$ Million)

Table 14. Global Cancer Respiratory Biopsy Market Share by Players (2020-2025)

Table 15. Global Top Cancer Respiratory Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Respiratory Biopsy as of 2024)

Table 16. Global Cancer Respiratory Biopsy Industry Ranking 2023 VS 2024

Table 17. Global 5 Largest Players Market Share by Cancer Respiratory Biopsy Revenue (CR5 and HHI) & (2020-2025)

Table 18. Global Key Players of Cancer Respiratory Biopsy, Headquarters and Area Served

Table 19. Global Key Players of Cancer Respiratory Biopsy, Product and Application

Table 20. Global Key Players of Cancer Respiratory Biopsy, Date of Enter into This Industry

Table 21. Mergers & Acquisitions, Expansion Plans

Table 22. Global Market Size by Type (2020-2025) & (US$ Million)

Table 23. Global Cancer Respiratory Biopsy Revenue Market Share by Type (2020-2025)

Table 24. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 25. Global Cancer Respiratory Biopsy Revenue Market Share by Type (2026-2031)

Table 26. Global Market Size by Application (2020-2025) & (US$ Million)

Table 27. Global Cancer Respiratory Biopsy Revenue Market Share by Application (2020-2025)

Table 28. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 29. Global Cancer Respiratory Biopsy Revenue Market Share by Application (2026-2031)

Table 30. North America Market Size by Type (2020-2031) & (US$ Million)

Table 31. North America Market Size by Application (2020-2031) & (US$ Million)

Table 32. North America Cancer Respiratory Biopsy Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Market Size by Country (2020-2031) & (US$ Million)

Table 34. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 35. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 36. Europe Cancer Respiratory Biopsy Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 38. China Market Size by Type (2020-2031) & (US$ Million)

Table 39. China Market Size by Application (2020-2031) & (US$ Million)

Table 40. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 41. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 42. Asia Cancer Respiratory Biopsy Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 44. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 45. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 46. Middle East, Africa, and Latin America Cancer Respiratory Biopsy Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 48. Owlstone Medical Company Details

Table 49. Owlstone Medical Business Overview

Table 50. Owlstone Medical Cancer Respiratory Biopsy Product

Table 51. Owlstone Medical Revenue (2020-2025) & (US$ Million)

Table 52. Owlstone Medical Recent Development

Table 53. Breath Diagnostics Company Details

Table 54. Breath Diagnostics Business Overview

Table 55. Breath Diagnostics Cancer Respiratory Biopsy Product

Table 56. Breath Diagnostics Revenue (2020-2025) & (US$ Million)

Table 57. Breath Diagnostics Recent Development

Table 58. Menssana Research Company Details

Table 59. Menssana Research Business Overview

Table 60. Menssana Research Cancer Respiratory Biopsy Product

Table 61. Menssana Research Revenue (2020-2025) & (US$ Million)

Table 62. Menssana Research Recent Development

Table 63. Sensigent Company Details

Table 64. Sensigent Business Overview

Table 65. Sensigent Cancer Respiratory Biopsy Product

Table 66. Sensigent Revenue (2020-2025) & (US$ Million)

Table 67. Sensigent Recent Development

Table 68. Alpha Szenszor Company Details

Table 69. Alpha Szenszor Business Overview

Table 70. Alpha Szenszor Cancer Respiratory Biopsy Product

Table 71. Alpha Szenszor Revenue (2020-2025) & (US$ Million)

Table 72. Alpha Szenszor Recent Development

Table 73. NanoScent Company Details

Table 74. NanoScent Business Overview

Table 75. NanoScent Cancer Respiratory Biopsy Product

Table 76. NanoScent Revenue (2020-2025) & (US$ Million)

Table 77. NanoScent Recent Development

Table 78. Spira Innovation Company Details

Table 79. Spira Innovation Business Overview

Table 80. Spira Innovation Cancer Respiratory Biopsy Product

Table 81. Spira Innovation Revenue (2020-2025) & (US$ Million)

Table 82. Spira Innovation Recent Development

Table 83. Syft Technologies Company Details

Table 84. Syft Technologies Business Overview

Table 85. Syft Technologies Cancer Respiratory Biopsy Product

Table 86. Syft Technologies Revenue (2020-2025) & (US$ Million)

Table 87. Syft Technologies Recent Development

Table 88. Breathe Biomedical Company Details

Table 89. Breathe Biomedical Business Overview

Table 90. Breathe Biomedical Cancer Respiratory Biopsy Product

Table 91. Breathe Biomedical Revenue (2020-2025) & (US$ Million)

Table 92. Breathe Biomedical Recent Development

Table 93. Vocxi Health Company Details

Table 94. Vocxi Health Business Overview

Table 95. Vocxi Health Cancer Respiratory Biopsy Product

Table 96. Vocxi Health Revenue (2020-2025) & (US$ Million)

Table 97. Vocxi Health Recent Development

Table 98. BREAX Biotech Company Details

Table 99. BREAX Biotech Business Overview

Table 100. BREAX Biotech Cancer Respiratory Biopsy Product

Table 101. BREAX Biotech Revenue (2020-2025) & (US$ Million)

Table 102. BREAX Biotech Recent Development

Table 103. ChromX Health Company Details

Table 104. ChromX Health Business Overview

Table 105. ChromX Health Cancer Respiratory Biopsy Product

Table 106. ChromX Health Revenue (2020-2025) & (US$ Million)

Table 107. ChromX Health Recent Development

Table 108. Sunvou Medical Company Details

Table 109. Sunvou Medical Business Overview

Table 110. Sunvou Medical Cancer Respiratory Biopsy Product

Table 111. Sunvou Medical Revenue (2020-2025) & (US$ Million)

Table 112. Sunvou Medical Recent Development

Table 113. MaiAoTech Company Details

Table 114. MaiAoTech Business Overview

Table 115. MaiAoTech Cancer Respiratory Biopsy Product

Table 116. MaiAoTech Revenue (2020-2025) & (US$ Million)

Table 117. MaiAoTech Recent Development

Table 118. Hanon Instruments Company Details

Table 119. Hanon Instruments Business Overview

Table 120. Hanon Instruments Cancer Respiratory Biopsy Product

Table 121. Hanon Instruments Revenue (2020-2025) & (US$ Million)

Table 122. Hanon Instruments Recent Development

Table 123. WIM Spirare Company Details

Table 124. WIM Spirare Business Overview

Table 125. WIM Spirare Cancer Respiratory Biopsy Product

Table 126. WIM Spirare Revenue (2020-2025) & (US$ Million)

Table 127. WIM Spirare Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer Respiratory Biopsy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global Cancer Respiratory Biopsy Market Share by Type: 2024 VS 2031

Figure 3. Mass Spectrometry Technology Based Respiratory Detection Features

Figure 4. Gas Chromatography-Mass Spectrometry Based Respiratory Detection Features

Figure 5. Sensor Based Respiratory Detection Features

Figure 6. Global Cancer Respiratory Biopsy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Global Cancer Respiratory Biopsy Market Share by Application: 2024 VS 2031

Figure 8. Lung Cancer Early Screening Case Studies

Figure 9. Colorectal Cancer Detection Case Studies

Figure 10. Liver Cancer Detection Case Studies

Figure 11. Esophageal Cancer Detection Case Studies

Figure 12. Others Case Studies

Figure 13. Cancer Respiratory Biopsy Report Years Considered

Figure 14. Global Cancer Respiratory Biopsy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Cancer Respiratory Biopsy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Cancer Respiratory Biopsy Market Share by Region: 2024 VS 2031

Figure 17. Global Cancer Respiratory Biopsy Market Share by Players in 2024

Figure 18. Global Top Cancer Respiratory Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Respiratory Biopsy as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Cancer Respiratory Biopsy Revenue in 2024

Figure 20. North America Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Cancer Respiratory Biopsy Market Share by Type (2020-2031)

Figure 22. North America Cancer Respiratory Biopsy Market Share by Application (2020-2031)

Figure 23. North America Cancer Respiratory Biopsy Market Share by Country (2020-2031)

Figure 24. United States Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Cancer Respiratory Biopsy Market Share by Type (2020-2031)

Figure 28. Europe Cancer Respiratory Biopsy Market Share by Application (2020-2031)

Figure 29. Europe Cancer Respiratory Biopsy Market Share by Country (2020-2031)

Figure 30. Germany Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. China Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. China Cancer Respiratory Biopsy Market Share by Type (2020-2031)

Figure 38. China Cancer Respiratory Biopsy Market Share by Application (2020-2031)

Figure 39. Asia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia Cancer Respiratory Biopsy Market Share by Type (2020-2031)

Figure 41. Asia Cancer Respiratory Biopsy Market Share by Application (2020-2031)

Figure 42. Asia Cancer Respiratory Biopsy Market Share by Region (2020-2031)

Figure 43. Japan Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. South Korea Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. China Taiwan Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Southeast Asia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. India Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Australia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Cancer Respiratory Biopsy Market Share by Type (2020-2031)

Figure 51. Middle East, Africa, and Latin America Cancer Respiratory Biopsy Market Share by Application (2020-2031)

Figure 52. Middle East, Africa, and Latin America Cancer Respiratory Biopsy Market Share by Country (2020-2031)

Figure 53. Brazil Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Mexico Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Turkey Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Israel Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. GCC Countries Cancer Respiratory Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. Owlstone Medical Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 60. Breath Diagnostics Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 61. Menssana Research Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 62. Sensigent Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 63. Alpha Szenszor Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 64. NanoScent Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 65. Spira Innovation Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 66. Syft Technologies Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 67. Breathe Biomedical Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 68. Vocxi Health Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 69. BREAX Biotech Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 70. ChromX Health Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 71. Sunvou Medical Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 72. MaiAoTech Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 73. Hanon Instruments Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 74. WIM Spirare Revenue Growth Rate in Cancer Respiratory Biopsy Business (2020-2025)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed